Sadeghi et al., 2018 - Google Patents
Interleukin-17 and interleukin-23 levels in gingival crevicular fluid of patients with chronic and aggressive periodontitisSadeghi et al., 2018
View PDF- Document ID
- 11412244812673704444
- Author
- Sadeghi R
- Sattari M
- Dehghan F
- Akbari S
- Publication year
- Publication venue
- Central European Journal of Immunology
External Links
Snippet
Results IL-17 concentration was significantly higher in the healthy group compared to the AgP and CP groups (p< 0.001), but there were no significant differences between the CP and AgP groups. IL-23 levels in the healthy group were significantly higher than that in the …
- 102000013691 Interleukin-17 0 title abstract description 62
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sadeghi et al. | Interleukin-17 and interleukin-23 levels in gingival crevicular fluid of patients with chronic and aggressive periodontitis | |
Gong et al. | Clinical, microbiologic, and immunologic factors of orthodontic treatment-induced gingival enlargement | |
Severino et al. | Expression of IL-6, IL-10, IL-17 and IL-8 in the peri-implant crevicular fluid of patients with peri-implantitis | |
Casado et al. | Interleukins 1β and 10 expressions in the periimplant crevicular fluid from patients with untreated periimplant disease | |
Górska et al. | Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis | |
Vernal et al. | Levels of interleukin‐17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis | |
Orozco et al. | Interleukin‐1 β, interleukin‐12 and interleukin‐18 levels in gingival fluid and serum of patients with gingivitis and periodontitis | |
Özçaka et al. | Interleukin‐17 and interleukin‐18 levels in saliva and plasma of patients with chronic periodontitis | |
Fonseca et al. | Cytokines expression in saliva and peri‐implant crevicular fluid of patients with peri‐implant disease | |
Tobón-Arroyave et al. | Correlation between salivary IL-1β levels and periodontal clinical status | |
Vernal et al. | Levels of cytokine receptor activator of nuclear factor κB ligand in gingival crevicular fluid in untreated chronic periodontitis patients | |
Liskmann et al. | Correlations Between Clinical Parameters and lnterleukin-6 and lnterleukin-10 Levels in Saliva from Totally Edentulous Patients with Peri-implant Disease. | |
Lim et al. | Interleukin 1β in symptomatic and asymptomatic human periradicular lesions | |
Himani et al. | Gingival crevicular fluid and interleukin‐23 concentration in systemically healthy subjects: their relationship in periodontal health and disease | |
Kurşunlu et al. | Gingival crevicular fluid interleukin-36β (-1F8), interleukin-36γ (-1F9) and interleukin-33 (-1F11) levels in different periodontal disease | |
de Sousa Rabelo et al. | Short-term effect of non-surgical periodontal treatment on local and systemic cytokine levels: role of hyperglycemia | |
Aleksandrowicz et al. | Analysis of IL-1β, CXCL8, and TNF-α levels in the crevicular fluid of patients with periodontitis or healthy implants | |
de Heens et al. | Cigarette smoking enhances T cell activation and a Th2 immune response; an aspect of the pathophysiology in periodontal disease | |
Nogueira‐Filho et al. | Longitudinal comparison of cytokines in peri‐implant fluid and gingival crevicular fluid in healthy mouths | |
Gürkan et al. | Gingival crevicular fluid transforming growth factor-β1 in several forms of periodontal disease | |
Cosgarea et al. | Bacterial and inflammatory behavior of implants in the early healing phase of chronic periodontitis. | |
Keles et al. | Gingival crevicular fluid levels of interleukin-18 and tumor necrosis factor-alpha in type 1 diabetic children with gingivitis | |
Leite et al. | Cytokine profiles and the dynamic of gingivitis development in humans | |
Ho et al. | Local and systemic expression profile of IL-10, IL-17, IL-27, IL-35, and IL-37 in periodontal diseases: a cross-sectional study | |
Sattari et al. | Effect of surgical flap on IL-1β and TGF-β concentrations in the gingival crevicular fluid of patients with moderate to severe chronic periodontitis |